March 29 (Reuters) - Redhill Biopharma Ltd RDHL.TA
* Re-Submission of rizaport U.S. New drug application (NDA)
to FDA and receipt of a new pdufa date are expected in Q4 of
2016
Source text for Eikon: ID:nGNXMQGKXa
Further company coverage: RDHL.TA
(Bengaluru Newsroom: +1-646-223-8780)